Literature DB >> 22150034

Learning about the safety of drugs--a half-century of evolution.

Jerry Avorn1.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22150034     DOI: 10.1056/NEJMp1110327

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Perception on adverse drug reaction reporting by physicians working in southern romania.

Authors:  Marian Sorin Paveliu; Simona Bengea-Luculescu; Mihai Toma; Silvia Fraga Paveliu
Journal:  Maedica (Bucur)       Date:  2013-03

2.  The Potential Return on Public Investment in Detecting Adverse Drug Effects.

Authors:  Krista F Huybrechts; Rishi J Desai; Moa Park; Joshua J Gagne; Mehdi Najafzadeh; Jerry Avorn
Journal:  Med Care       Date:  2017-06       Impact factor: 2.983

Review 3.  Drugs and Medical Devices: Adverse Events and the Impact on Women's Health.

Authors:  Jennifer L Carey; Nathalie Nader; Peter R Chai; Stephanie Carreiro; Matthew K Griswold; Katherine L Boyle
Journal:  Clin Ther       Date:  2017-01-07       Impact factor: 3.393

Review 4.  Assuring safety of inherently unsafe medications: the FDA risk evaluation and mitigation strategies.

Authors:  Lewis S Nelson; Meredith Loh; Jeanmarie Perrone
Journal:  J Med Toxicol       Date:  2014-06

Review 5.  FDA Policy and Cardiovascular Medicine.

Authors:  Joseph S Ross; Aaron S Kesselheim
Journal:  Circulation       Date:  2015-09-22       Impact factor: 29.690

6.  Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.

Authors:  Mark Bounthavong; Emily Beth Devine; Melissa L D Christopher; Michael A Harvey; David L Veenstra; Anirban Basu
Journal:  Health Serv Res       Date:  2019-07-17       Impact factor: 3.402

7.  A statewide controlled trial intervention to reduce use of unproven or ineffective breast cancer care.

Authors:  Liliana E Pezzin; Purushottam Laud; Joan Neuner; Tina W F Yen; Ann B Nattinger
Journal:  Contemp Clin Trials       Date:  2016-08-10       Impact factor: 2.226

8.  Federal legislation and the advancement of neonatal drug studies.

Authors:  Jason R Wiles; Alexander A Vinks; Henry Akinbi
Journal:  J Pediatr       Date:  2012-10-27       Impact factor: 4.406

Review 9.  Clinical translation of immunomodulatory therapeutics.

Authors:  Amanda Nash; Samira Aghlara-Fotovat; Andrea Hernandez; Christopher Scull; Omid Veiseh
Journal:  Adv Drug Deliv Rev       Date:  2021-07-27       Impact factor: 17.873

Review 10.  The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses.

Authors:  Anand Kumar Gupta; Sonali Das; Mohd Kamran; Sarfaraz Ahmad Ejazi; Nahid Ali
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.